ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,049, issued on Feb. 17, was assigned to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (Seoul, South Korea).
"Pharmaceutical composition containing SIRT7 inhibitor for preventing or treating allergic diseases" was invented by Tae-hoon Kim (Seoul, South Korea), Junhyoung Byun (Uijeongbu-si, South Korea) and Kijeong Lee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to treatment and prevention of allergic diseases and, specifically, to an allergic disease immunomodulation method, which suppresses SIRT7 of nasal cavity epithelial cells to inhibit allergy mediators. The present invention suppresses SI...